UBS Group’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.38M | Buy |
259,775
+178,350
| +219% | +$2.32M | ﹤0.01% | 3394 |
|
|
2025
Q1 | $2.06M | Sell |
81,425
-133,621
| -62% | -$3.37M | ﹤0.01% | 3679 |
|
|
2024
Q4 | $7.39M | Buy |
215,046
+190,885
| +790% | +$6.56M | ﹤0.01% | 2629 |
|
|
2024
Q3 | $1.19M | Buy |
24,161
+5,796
| +32% | +$286K | ﹤0.01% | 3459 |
|
|
2024
Q2 | $1.11M | Sell |
18,365
-13,599
| -43% | -$818K | ﹤0.01% | 3322 |
|
|
2024
Q1 | $1.65M | Sell |
31,964
-2,693
| -8% | -$139K | ﹤0.01% | 3141 |
|
|
2023
Q4 | $1.4M | Buy |
34,657
+16,434
| +90% | +$663K | ﹤0.01% | 3169 |
|
|
2023
Q3 | $508K | Sell |
18,223
-729
| -4% | -$20.3K | ﹤0.01% | 3594 |
|
|
2023
Q2 | $546K | Buy |
18,952
+11,301
| +148% | +$325K | ﹤0.01% | 3753 |
|
|
2023
Q1 | $128K | Buy |
7,651
+2,263
| +42% | +$37.7K | ﹤0.01% | 4672 |
|
|
2022
Q4 | $68.3K | Buy |
5,388
+4,339
| +414% | +$55K | ﹤0.01% | 5329 |
|
|
2022
Q3 | $13K | Buy |
+1,049
| New | +$13K | ﹤0.01% | 6961 |
|
|
2022
Q2 | – | Sell |
-3,888
| Closed | -$48K | – | 9662 |
|
|
2022
Q1 | $48K | Buy |
3,888
+282
| +8% | +$3.48K | ﹤0.01% | 5517 |
|
|
2021
Q4 | $40K | Buy |
+3,606
| New | +$40K | ﹤0.01% | 6023 |
|